1. Update on Metastatic Uveal Melanoma: Progress and Challenges

   • Francesco Spagnolo
   • Virginia Picasso
   • Paola Queirolo

   Review Article 21 March 2016 Pages: 161 - 172

2. Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors

   • Genevieve Evin

   Review Article 29 March 2016 Pages: 173 - 194

   

3. Assessing the Immunogenicity of Biopharmaceuticals

   • Carlos Pineda
   • Gilberto Castañeda Hernández
   • Claudio Carini

   Review Article Open access 20 April 2016 Pages: 195 - 206

   

4. Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis

   • Xinlin Chen
   • Jiangtao Hou
   • Fengbin Liu

   Systematic Review 27 April 2016 Pages: 207 - 217

   

5. Anagrelide and Mutational Status in Essential Thrombocythemia

   • Alessandra Iurlo
   • Daniele Cattaneo
   • Agostino Cortelezzi

   Short Communication 04 April 2016 Pages: 219 - 223

6. Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab

   • Hector A. Cuello
   • Valeria I. Segatori
   • Mariano R. Gabri

   Short Communication 06 April 2016 Pages: 225 - 231

   

7. Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets

   • Anna Hausberger
   • William C. Lamanna
   • Johann Holzmann

   Original Research Article 30 March 2016 Pages: 233 - 242

   

8. Shingles (Herpes Zoster) Vaccine (Zostavax^®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia

   • Gillian M. Keating

   Adis Drug Evaluation 17 May 2016 Pages: 243 - 254